Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Review Article

Deciphering the Correlation between the Emergence of Lung Carcinoma Associated with Tuberculosis-related Inflammation

Author(s): Prashant Chauhan, Pratibha Pandey*, Seema Ramniwas, Fahad Khan and Ramish Maqsood

Volume 25, Issue 4, 2025

Published on: 31 May, 2024

Page: [291 - 299] Pages: 9

DOI: 10.2174/0118715303301146240522095638

Price: $65

Open Access Journals Promotions 2
conference banner
Abstract

Lung cancer and tuberculosis (TB) are classified as the second-most life-threatening diseases globally. They both are exclusively represented as major public health risks and might exhibit similar symptoms, occasionally diagnosed simultaneously. Several epidemiological studies suggest that TB is a significant risk factor for the progression of lung cancer. The staggering mortality rates of pulmonary disorders are intrinsically connected to lung cancer and TB. Numerous factors play a pivotal role in the development of TB and may promote lung carcinogenesis, particularly among the geriatric population. Understanding the intricacies involved in the association between lung carcinogenesis and TB has become a crucial demand of current research. Consequently, this study aims to comprehensively review current knowledge on the relationship between tuberculosis-related inflammation and the emergence of lung carcinoma, highlighting the impact of persistent inflammation on lung tissue, immune modulation, fibrosis, aspects of reactive oxygen species, and an altered microenvironment that are linked to the progression of tuberculosis and subsequently trigger lung carcinoma.

Keywords: Lung cancer, tuberculosis (TB), chronic inflammation, immune checkpoint inhibitors (ICIs), reactive oxygen species (ROS), pulmonary disorders.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy